Inogen (INGN) Research & Development (2013 - 2026)
Inogen (INGN) reported Research & Development of $5.1 million for Q1 2026, up 26.35% year-over-year from $4.0 million in Q1 2025, and down 4.12% quarter-over-quarter from $5.3 million in Q4 2025.
Inogen (INGN) Research & Development (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Research & Development data on file, last reported at $5.1 million in Q1 2026.
- Research & Development for Q1 2026 came in at $5.1 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.5 million (up 7.32% YoY), and the FY2025 annual result was $19.4 million, down 10.23% from the prior year.
- Research & Development retreated to $5.1 million in Q1 2026 per INGN's latest filing, from $5.3 million in the prior quarter.
- Over five years, Research & Development peaked at $6.7 million in Q4 2023 and troughed at $3.5 million in Q3 2024.
- A 5-year average of $5.2 million and a median of $5.3 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development jumped 47.08% in 2022, then slumped 38.67% in 2025.
- A 5-year view of Research & Development shows it stood at $5.9 million in 2022, then rose by 13.14% to $6.7 million in 2023, then slipped by 12.15% to $5.9 million in 2024, then retreated by 9.87% to $5.3 million in 2025, then decreased by 4.12% to $5.1 million in 2026.
- Business Quant data shows INGN's Research & Development at $5.1 million in Q1 2026, $5.3 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.32 Mn |
| Sep 30, 2025 | 4.84 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 5.36 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Jun 30, 2021 | 4.12 Mn |